Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease

Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease

US Patent 10912751 · Granted Feb 9, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivati2025
Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and me2023
Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and me2023
Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and me2023
Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivati2023
Fixed dose combinations and formulations comprising ETC1002 and one or more stat2021
Fixed dose combinations and formulations comprising ETC1002 and one or more stat2021
Fixed dose combinations and formulations comprising ETC1002 and one or more stat2021
Apolipoprotein mixtures2017
Statin-carboxyalkylether combinations2013
Fourier transform mass spectrometry of complex biological samples2005
Fourier transform mass spectrometry of complex biological samples2004